Table 3 Operating conditions and adequacy parameters of the different dialysis treatments adopted in the study
From: Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra
| Â | ol-HDF (run-in) | HFR-S | HFR |
|---|---|---|---|
Session length (min) | 233 ± 18 | 235 ± 25 | 233 ± 16 |
Qb (mL/min) | 313 ± 31 | 312 ± 31 | 301 ± 32 |
Qd (mL/min) | 500 | 500 | 500 |
Body weight loss (kg/session) | 2.8 ± 0.8 | 2.7 ± 1.1 | 2.8 ± 0.9 |
(Re)infusion volume (L/session) | 14.9 ± 2.5 | 12.9 ± 2.9 | 13.4 ± 4.1 |
(Re)infusion rate (mL/min) | 64.2 ± 9.6 | 54.9 ± 13.4 | 57.5 ± 13.2 |
eqKt/V | 1.22 ± 0.25 | 1.17 ± 0.32 | 1.12 ± 0.23 |
ePCR (g/Kg/day) | 1.4 ± 0.6 | 1.07 ± 0.54 | 1.08 ± 0.35 |